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Abstract
Background: The cause of autoimmunity, which is unknown, is investigated from a different angle, i.e., the defect in
immune ‘system’, to explain the cause of autoimmunity.
Methodology/Principal Findings: Repeated immunization with antigen causes systemic autoimmunity in mice otherwise not
prone tospontaneous autoimmune diseases. Overstimulationof CD4
+ T cells led tothe development of autoantibody-inducing
CD4
+ T( aiCD4
+ T) cell which had undergone T cell receptor (TCR) revision and was capable of inducing autoantibodies. The
aiCD4
+ T cell was induced by de novo TCR revision but not by cross-reaction, and subsequently overstimulated CD8
+ T cells,
driving them to become antigen-specific cytotoxic T lymphocytes (CTL). These CTLs could be further matured by antigen cross-
presentation, after which they caused autoimmune tissue injury akin to systemic lupus erythematosus (SLE).
Conclusions/Significance: Systemic autoimmunity appears to be the inevitable consequence of over-stimulating the host’s
immune ‘system’ by repeated immunization with antigen, to the levels that surpass system’s self-organized criticality.
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Introduction
Since ‘clonal selection theory of immunity’ of F. Macfarlane Burnet
and subsequent molecular biological discoveries on V(D)J recombi-
nation and the diversity and individuality of immune response, how
autoimmunity arises remains unclear. Apart from the term ‘autoim-
munity’ which is now ready-made, in the present study, we tried to see
the pathogenesis of autoimmunity from different angle and test the
i n t e g r i t yo fi m m u n e‘ s y s t e m ’ .T h em e t h o dw eh a v ec h o s e nw a st o
stimulate the system maximally by antigen to the levels far beyond its
steady-state just like testing the capability of automobile. In a perfectly
reproducible experiments in which the mice not prone to autoimmune
diseases were immunized repeatedly with antigen, we have unexpect-
edly and surprisingly discovered that overstimulation of immune
system beyond its self-organized criticality inevitably leads to systemic
autoimmunity.Subsequent detailed molecular analyses revealed in the
first that autoantibodies are induced not by cross reaction to antigen
but by de novo T cell receptor (TCR) revision. Second, final maturation
of effector cytotoxic T lymphocyte (CTL) via antigen cross-presenta-
tion is sine qua non for generating autoimmune tissue injury. Most
importantly, we now show that autoimmunity arises not from ‘auto-
immunity’, but as a natural consequence of normal immune response
when stimulated maximally beyond system’s self-organized criticality.
Results
Induction of Autoantibodies
Consistent with the common observation that T cells become
anergic after strong stimulation with antigen [1], we observed
that 26 immunization with staphylococcus enterotoxin B
(SEB) caused SEB-reactive Vb8
+CD4
+ T cells from BALB/c
mice to become anergized. However, these cells recovered
from anergy to divide and produce IL-2 after further immuni-
zation 86with SEB (Figure S1A). This was accompanied by the
induction of autoantibodies, including IgG- and IgM-rheumatoid
factor (RF), anti-Sm antibody, and in particular, RF reactive
against galactose-deficient IgG, typically found in human
autoimmunity [2] (Figure 1A). Autoantibodies can also be
induced by other conventional antigens, including ovalbumin
(OVA) or keyhole limpet hemocyanin (KLH) (Figure S2) as long
as immunizing antigen is correctly presented to T cells (Figure
S1B). CD4
+ T cells of repeatedly-immunized mice become fully
matured, expressing CD45RB
lo, CD27
lo and CD122
hi (data not
shown), and these primed CD4
+ T cells can confer RF generation
in naı ¨ve recipients following adoptive transfer (Figure 1B). The
induction of autoantibodies is independent of CD8
+ T cells or
MHC class I-restricted antigen presentation for the following
reasons. First, both RF and anti-dsDNA antibody can be
consistently induced upon repeated immunization of b2-micro-
globulin (b2m)-deficient BALB/c mice with OVA. b2m-deficient
mice are deficient in CD8
+ T cells, which are reduced to
,0.8% of splenic T cells [3] (Figure S3). Second, the ability to
induce autoantibodies was transferable from OVA-immunized
BALB/c mice to b2m-deficient mice solely via CD4
+ T cells
(Figure 1C). Thus, CD4
+ T cells from repeatedly-immunized
mice acquire the ability to induce autoantibodies. We refer to
these as autoantibody-inducing CD4
+ T( aiCD4
+ T) cells in this
communication.
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8382Figure 1. Induction of autoantibodies and proteinuria. BALB/c mice were repeatedly injected i.p. with 25 mg SEB, 500 mg OVA or PBS every 5 d.
(A) Serum IgG- and IgM-RFs, anti-galactose-deficient IgG and anti-Sm antibodies were measured using ELISA. The arbitrary unit (AU) of 1.0 is equivalent
to the titer obtained from sera of prototypic autoimmune MRL/lpr mice. Data from each mouse are connected by dotted lines. (B) Adoptive transfer of
splenic B, T, CD4
+ To rC D 8
+ T cells of SEB-, OVA- or PBS-immunized BALB/c mice into naı ¨ve BALB/c mice. The recipient mice were given single i.p.
injection of 25 mg SEB or 500 mg OVA 24 h after cell transfer, and autoantibodies were measured 2 weeks later. (C) Adoptive transfer of cells from
OVA-immunized BALB/c mice into b2m-deficient mice.
doi:10.1371/journal.pone.0008382.g001
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To further clarify the characteristics of aiCD4
+ T cells, we
examined their TCR repertoire by spectratyping of their
complementarity determining region 3 (CDR3) [4]. Combinato-
rial assessment of Vb and Jb showed that the CDR3 length profiles
of CD4
+ splenocytes in mice immunized either 86with PBS or 26
with SEB fit a normal Gaussian curve, typical of a diverse and
unbiased TCR repertoire (Figure 2A). However, splenocytes, but
not thymocytes, from mice immunized 86 with SEB showed
skewed length profiles, suggesting that TCR revision was in
progress at periphery of the spleen. Genes encoding components
of the V(D)J recombinase complex were specifically re-expressed
in mice immunized 86 with SEB, including the recombination-
activating genes 1 and 2 (RAG1/2), terminal deoxynucleotidyl
transferase (TdT) and surrogate TCRa chain (pTa) [5] (Figure 2B).
The RAG1 gene is expressed in vivo after immunization 86with
Figure 2. TCR revision upon repeated immunization with antigen. (A) TCR CDR3 length profiles of mice immunized 86with PBS, 26or 86
with SEB. TCR repertoire of splenic CD4
+ T cell was skewed only after immunization 86with SEB. (B) Expression of V(D)J recombinase complex and
related molecules in the spleen of PBS- or SEB-injected BALB/c mice. (C) GFP
+ cells in the Vb8
+CD4
+ T population of rag1/gfp knock-in mice. IgG-RF as
induced in rag1/gfp knock-in mice after immunization 86with SEB (lower left). The GFP
+ T cell fraction was also increased among Vb8
+CD4
+ T cells
(mean 6 SD, 4–5 mice/group). (D) TCRa chain revision in the spleen of mice immunized 86with SEB was determined by LM-PCR detection of dsDNA
breaks at the RSS flanking the TCRAV2, with PCR-amplified TCRa constant region (TCRAC) as a DNA quality control.
doi:10.1371/journal.pone.0008382.g002
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serum RF was increased in conjunction with an increase of GFP-
expressing Vb8
+CD4
+ T cells in the spleen. To directly prove that
V(D)J recombination took place at the periphery in spleen, we
used ligation-mediated PCR (LM-PCR) to detect blunt-end DNA
fragments harboring a rearranged coding V region flanked by
recombination signal sequences (RSS) [7,8]. We identified
rearranged intermediates corresponding to the TCRa variable
region 2 (TCRAV2) in the splenocytes of mice immunized 86with
SEB (Figure 2D). These findings indicate that repeated immuni-
zation with conventional antigen can induce the generation of
aiCD4
+ T cells which have undergone TCR revision and are
capable of stimulating B cells [9]. This observation is in line with
previous findings showing that such somatic mutations occur often
in lymphocytes, a process which is considered to be a major
stochastic element in the pathogenesis of autoimmunity [10,11].
Thus, overstimulation of CD4
+ T cells by repeated immunization
with antigen and induction of full maturation inevitably leads to
the generation of aiCD4
+ T cells which have undergone TCR
revision and are capable of inducing autoantibodies. Importantly,
the present study shows that such aiCD4
+ T cells are induced by de
novo TCR revision but not by cross-reaction to antigen.
Induction of Autoimmune Tissue Injury
Repeated immunization with OVA can also lead to autoim-
mune tissue injury and the production of autoantibodies reactive
against IgG, Sm and dsDNA (Figure 3 and Figure S2A). Serum
immune complex (IC), proteinuria, and the deposition of IC and
OVA in the kidney were noted in mice immunized 126with OVA
(Figure 3A). Typical diffuse proliferative glomerular lesions were
seen in the kidney, and these glomeruli were infiltrated with CD8
+
T cells. These observations resemble the clinical features observed
in lupus patients, who typically exhibit an increase in CD8
+ T
cells in the peripheral blood and infiltration of CD8
+ T cells in
kidney [12,13]. Immunization of mice 126with OVA led to re-
expression of the V(D)J recombinase complex and enlargement of
the spleen (Figure S4A), and an increase in anti-dsDNA antibody,
which is uniquely linked to autoimmune tissue injury in lupus
nephritis [14] (Figure S2A). Pathological findings included diffuse
membranous (wire-loop) and/or proliferative glomerulonephritis
in the kidney (Figure 3A), infiltration of plasma cells around
hepatic bile ducts (Figure S4B), enlarged lymphoid follicles with
marked germinal center in spleen (Figure S4B), occasional
lymphocyte infiltration into the salivary glands (data not shown),
lymphoid cell infiltration into the thyroid, and perivascular
infiltration of neutrophils and macrophages into the skin dermis
of the auricle (Figure S4B). The lupus band test, diagnostic of SLE,
was positive in the skin at the epidermal-dermal junction
(Figure 3B).
Mechanism of Autoimmune Tissue Injury
It has been shown previously that IFNc is increased in
association with autoimmune tissue injury [15–17]. Consistent
with this, we found that the number of IFNc
+CD8
+ T cells, but
not regulatory T or T helper 17 cells, was increased following
immunization 126 with OVA (Figure 4A and data not shown).
We also observed an expansion of IFNc-producing effector/
memory CD8
+ T cells, which are necessary for adaptive immunity
[18] (Figure 4A). These IFNc-producing CD8
+ T cells were
observed to have infiltrated into OVA-deposited glomeruli of
OVA-immunized mice (Figure 3A). CD8
+ T cells are required for
tissue injury based on the following observations. First, the transfer
of CD8
+ T cells can induce renal lesions in mice (Figure 4B), as
well as the generation of new IFNc
+CD8
+ T cells in the spleens of
recipient mice following cell transfer (Figure S5). Second,
autoimmune tissue injury is not induced by the transfer of CD8
+
T cells from OVA-immunized wild-type mice into b2m-deficient
mice (Figure 1C). And finally, CD8
+ T cell transfer must be
accompanied by at least a 16booster immunization with OVA to
induce autoimmune tissue injury in the recipient mice (Figure S6).
The findings indicate that full-matured, IFNc-producing effector
CD8
+ T cells are required for the induction of autoimmune tissue
injury, provided that the relevant antigen is correctly presented on
the target organs. These are well-established characteristic of CTL
and not novel. We show, however, that (i) CTL is induced through
an immune, but not ‘autoimmune’, process, and that (ii)
autoimmune tissue injury inevitably occurs when CD8
+ T cells
are overstimulated to become matured effector CTLs. The latter
means that regardless of how CTL is induced, the consequence of
CTL over-induction is immune tissue injury.
Antigen Cross-Presentation
We next show that antigen cross-presentation is required for the
induction of CTL and tissue injury. To test this, we co-cultured
OVA-pulsed dendritic cells (DC) from mice immunized 126with
OVA together with T cells from OVA-TCR transgenic DO11.10
mice exclusively expressing OVA-reactive TCR [19]. We show
that OVA-reactive DO11.10 CD8
+ T cells are activated upon co-
culture with OVA-pulsed DCs (Figure 4C and Figure S7). Further,
autoimmune tissue injury and the increase in IFNc
+CD8
+ T cells,
but not of autoantibody generation, were both abrogated by
adding chloroquine (CQ), an inhibitor of antigen cross-presenta-
tion (Figure 4C). This indicates that antigen cross-presentation is
required for the expansion of IFNc-producing CD8
+ T cells and
autoimmune tissue injury.
aiCD4
+ T Cell Helps CD8
+ T Cell to Induce Tissue Injury
Since CTL appear to play a rather passive role in autoimmu-
nity, we next studied whether or not aiCD4
+ T cell help is required
for the induction of autoimmune tissue injury. Since anti-CD4
treatment almost abrogates generation of IFNc-producing CD8
+
T cell and autoimmune tissue injury in OVA-immunized BALB/c
mice (Figure S8), to test whether this CD4
+ T cell-mediated help is
mediated by aiT cells or antigen-specific T cells, we have
transferred CD4
+ T cells from mice immunized 126 with KLH
into CD4
+ T-depleted BALB/c mice immunized 86 with OVA
(Figure 4D). Because full-matured IFNc
+ CTLs do not develop
with less than 86 immunization with OVA (Figure S9), this
experiment can test the ability of aiCD4
+ T cells that have
undergone TCR revision to promote the maturation of OVA-
specific CTL. The result showed that both autoimmune tissue
injury and OVA-specific IFNc
+CD8
+ T cells arose in these mice
after transfer, indicating that aiCD4
+ T cells with de novo TCR
revision are required for the maturation of CD8
+ T cell and
autoimmune tissue injury (Figure 4D).
Discussion
The present findings are consistent with the current consensus
that CD4
+ T cells normally die via activation-induced cell death
(AICD) after repeated exposure to a single antigen, while naı ¨ve
CD4
+ T cells having a ‘cross-reactive’ TCR with lower affinity can
be activated through repeated exposure to the same antigen and
survive due to weak TCR signaling, ultimately acquiring
autoreactivity [20]. We show here, however, that aiCD4
+ T cells
are induced not by cross-reaction, but by de novo TCR revision.
The aiCD4
+ T cells thus generated induce not only autoantibodies
but also full-maturation of CD8
+ T cells leading to autoimmune
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PLoS ONE | www.plosone.org 4 December 2009 | Volume 4 | Issue 12 | e8382Figure 3. Induction of autoimmune tissue injury. BALB/c mice were injected i.p. with 500 mg OVA every 5 d. (A) Serum IC measured 2 d after
final immunization, expressed as AU. Proteinuria assessed 9 d after final immunization: grades 1, 2 and 3 represent 30–100 mg/dl, 100–300 mg/dl and
300–1000 mg/dl of urinary protein, respectively (upper left). Representative histopathology of kidneys from mice immunized 126with PBS or OVA
(lower left) (H&E staining, bar =20 mm; original magnification6400): glomerular expansion with cellular infiltration including eosinophils seen under
the same magnification. Immunohistochemistry for deposited IC, IgG, C3 and OVA (upper right) (bar =50 mm; original magnification6200), and cells
infiltrated into glomeruli (bar =20 mm; original magnification6300), stained in serial tissue sections using anti-CD8a (53–6.7) and anti-IFNc (R4-6A2)
monoclonal antibodies, in the specimens of mice immunized 126 with OVA (lower right). (B) Lupus band test stained with anti-IgG and anti-C3
antibodies (bar =20 mm; original magnification 6400).
doi:10.1371/journal.pone.0008382.g003
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+ T cells and antigen cross-presentation. (A) Spleen cells stimulated with 50 ng/ml phorbol myristate acetate
(PMA) and 500 ng/ml ionomycin for 4 h in the presence of brefeldin A (10 mg/ml) and stained for intracellular IFNc (upper). Subsets of CD8
+ T cells
categorized into naı ¨ve (CD44
lowCD62L
high), effector (CD44
highCD62L
low), and memory (CD44
highCD62L
high) fractions (middle). Flow cytometry of IFNc
+
cells within naı ¨ve or effector/memory CD8
+ T cell populations. Spleen cells were separated into naı ¨ve (CD44
low) and effector/memory (CD44
high) cells
using CD44 MACS beads, and IFNc
+ cells within the CD8
+ T population was evaluated (lower). (B) Adoptive transfer of splenocytes of OVA-immunized
BALB/c mice into naı ¨ve recipients. The recipients were injected with 500 mg OVA 24 h after cell transfer, and proteinuria examined 2 weeks later. (C)
Cross-presentation of OVA to CD8
+ T cells. Splenic CD11c
+ DC from OVA-immunized or control mice were incubated in the presence (OVA(+)) or
absence (OVA(2)) of 1 mg/ml OVA with or without chloroquine (CQ) (20 mg/ml) for 3 h, followed by a co-culture with KJ1-26
+CD8
+ T cells of DO11.10
transgenic mice for 24 h to examine surface expression of CD69 (upper). Inhibition of cross-presentation in vivo by administration of 250 mg CQ per
mouse 3 h prior to immunization with OVA or PBS. IFNc
+CD8
+ T cells (middle), autoantibodies and proteinuria (lower) after 126immunization. (D)
Requirement of autoantibody-inducing CD4
+ T cells for CD8
+ T cell-mediated autoimmune tissue injury. BALB/c mice were immunized 126with KLH,
and CD4
+ T cells were isolated using MACS beads. Cells were transferred into the anti-CD4 antibody-treated recipient mice immunized 86with OVA.
Percent matured CTL, i.e., IFNc
+CD8
+ T cells, and proteinuria were measured 2 weeks after booster immunization 16with KLH.
doi:10.1371/journal.pone.0008382.g004
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PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8382tissue injury akin to human SLE. Thus, induction of aiCD4
+ T
cells is a critical step, and subsequent induction of effector CTL is
a critical next step in the development of autoimmunity [21,22].
The question of how autoimmunity is triggered can therefore be
deduced to the quantitative response of host against immunizing
antigen, i.e., the ability of host to present and/or cross-present
antigen. It then follows that the ability of certain antigens such as
measles virus to cause autoimmunity may be due to their ability, in
conjunction with its ability to present antigen, to overstimulate
CD4
+ and/or CD8
+ T cells of certain hosts beyond integrity of
their immune system. Living organisms are constantly exposed to
a broad range of environmental antigens, as exemplified by the
recent re-emergence of measles virus infection among a subpop-
ulation of Japanese young adults who were not vaccinated against
the virus. We therefore conclude that systemic autoimmunity
necessarily takes place when host’s immune ‘system’ is overstim-
ulated by external disturbance, i.e., repeated exposure to antigen,
to the levels that surpass system’s self-organized criticality, and
propose here ‘self-organized criticality theory’ explaining the cause
of autoimmunity.
Materials and Methods
Ethics Statement
This study was approved by the Institutional Animal Care and
Use Committee and carried out according to the Kobe University
Animal Experimental Regulations.
Reagents
APC (allophycocyanin)-conjugated antibody against CD4
(RM4-5), and PE-conjugated antibodies against CD62L (MEL-
14), CD69 (H1.2F3) and were purchased from BioLegend (San
Diego, CA); FITC-conjugated antibodies against CD44 (IM7.8.1)
and DO 11.10 clonotypic TCR (KJ1-26) and PE-conjugated rat
IgG1 isotype control from CALTAG Laboratories (Burlingame,
CA); PE-Cy5 (phycoerythrin-cyanin 5)-conjugated antibody
against CD8a (53-6.7), PE-conjugated antibodies against Vb8
TCR (F23.1) and IFNc (XMG1.2) from BD PharMingen (San
Diego, CA).
Animal Studies
Animal studies with BALB/c female mice (Japan SLC, Inc.,
Hamamatsu, Japan) and DO11.10 TCR transgenic mice [19]
(Jackson Laboratory, Bar Harbor, ME), b2m-deficient mice [3]
and rag1/gfp knock-in mice [6] of BALB/c background were
performed with the approval of the Institutional Review Board.
Mice (8 weeks-old) were immunized with 25 mg SEB (Toxin
Technologies, Sarasota, FL), 500 mg OVA (grade V; Sigma, St.
Louis, MO), 100 mg KLH (Sigma) or PBS by means of i.p.
injection every 5 d.
Frozen sections of kidney and dermis were stained for C3, IgG
or OVA using goat anti-C3 (Bethyl laboratories, Inc., Montgom-
ery, TX) and Alexa Fluor 488-conjugated anti-goat IgG antibodies
(Molecular Probes, Eugene, OR), Alexa Fluor 594-conjugated
anti-mouse IgG antibody (Molecular Probes), or rabbit anti-OVA
antibody (Sigma). For CD8 or IFNc staining, paraffin-embedded
sections of kidney were stained with rat antibodies against CD8a
(53-6.7; BD PharMingen) or IFNc (R4-6A2; BD PharMingen),
followed by reaction with VECTASTAIN Elite ABC rat IgG kit
(Vector, Burlingame, CA).
To detect intracellular IFNc, cells (1610
6/ml) were stimulated
with 50 ng/ml phorbol myristate acetate (PMA; Sigma) and
500 ng/ml ionomycin (Sigma) in the presence of brefeldin A
(10 mg/ml; Sigma). After 4 h, cells were stained with anti-CD8
antibody, followed by fixation with 2% formaldehyde, permeabi-
lization with 0.5% saponin (Sigma) and stained for IFNc.
For adoptive cell transfer, B, T, CD4
+ T and CD8
+ T cells were
isolated from spleens to .90% purity using MACS beads
(Miltenyi Biotec, Germany). The cells were transferred into naı ¨ve
BALB/c or b2m-deficient mice via i.p. (5610
6/mouse) or i.v.
(2.5610
7/mouse) injection. The recipients received a single i.p.
injection of 25 mg SEB or 500 mg OVA 24 h after cell transfer,
and sera, urine and organ of recipients were studied 2 weeks
afterwards.
BALB/c mice were injected i.p. with 200 mg anti-CD4 antibody
(GK1.5; BioLegend) to deplete CD4
+ T cell 24 h after
immunization 86with OVA. Four days later, CD4
+ T cells from
mice immunized 126 with KLH were transferred to the CD4
+
T-depleted mice. The recipient mice received a single i.p. injection
of 100 mg KLH 24 h after the cell transfer.
Assay for Mediators
Sera were assayed for anti-Sm antibody using Sm antigen
(ImmunoVision, Springdale, AR), RF (Shibayagi Co., Gunma,
Japan), RF for galactose-deficient IgG (Eisai Co., Ltd., Tokyo,
Japan) and anti-dsDNA antibody using dsDNA (Worthington
Biochemical Co., Lakewood, NJ) after digestion by S1 nuclease
(Promega, Madison, WI). Serum IC was detected using goat anti-
C3 antibody (Bethyl Lab.).
CDR3 Length Spectratyping
cDNAs from thymocytes and CD4
+ splenocytes were subjected
to PCR amplification using Cb- and Vb8-specific primers.
Amplified products were subjected to run-off reactions using three
fluorophore-labeled Jb primers, Jb1.1, Jb1.3 and Jb2.4, and
analyzed by GeneScan software (Perkin-Elmer Applied Biosys-
tems, Emeryville, CA) [4].
RT-PCR
Total RNA was reversely transcribed to cDNA and amplified by
PCR [23]. The products were fractionated by electrophoresis and
transferred to nylon membranes (Roche Diagnostics, Mannheim,
Germany). The membranes were hybridized to fluorescein end-
labeled probesand visualized by alkaline phosphatase(ALP)-labeled
anti-fluorescein antibody and Gene Images CDP-Star chemilumi-
nescence reaction (Amersham Pharmacia Biotech, Piscataway, NJ).
The primers and probes were: 59-CCAAGCTGCAGACATTC-
TAGCACTC-39 (forward), 59-CAACATCTGCCTTCACGTCG-
ATCC-39 (reverse) and 59-AACATGGCTGCCTCCTTGCCG-
TCTACCCT-39 (probe) for RAG1 [24]; 59-CACATCCACAAG-
CAGGAAGTACAC-39 (forward), 59-GGTTCAGGGACATCT-
CCTACTAAG-39 (reverse) and 59-GCAATCTTCTCTAAAGA-
TTCCTGCTACCT-39 (probe) for RAG2 [24]; 59-GAACAAC-
TCGAAGAGCCTTCC-39 (forward), 59-CAAGGGCATCCGT-
GAATAGTTG-39 (reverse) and 59-ATTCGGTCACCCACATT-
GTGGCAGAGAAC-39 (probe) for TdT; 59-CAACTGGGTCAT-
GCTTCTCC-39 (forward), 59-TGGCTGTCGAAGATTCCC-39
(reverse) and 59-CCGTCTCTGGCTCCACCCATCACACTG-
CT-39 (probe) for pTa.
LM-PCR
DNA (1 mg) was ligated to 20 mM BW linker using T4 ligase
(Takara Bio Inc., Shiga, Japan) [25]. Primary PCR was performed
using 200 ng ligated DNA, BW-1HR primer (59-CCGGGA-
GATCTGAATTCGTGT-39) [24], primer specific for 39 flanking
sequence of TCRAV2 (59-AGATGATACAGAGACAAAATGT-
GAGC-39) and 2 U of AmpliTaq Gold DNA polymerase (Applied
Cause of Autoimmunity
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1 ml of the first PCR product (diluted 1/100), BW-1HR, and nested
primerspecificfor 39 flanking sequence of TCRAV2(59-TATTGTG-
GATGCTAACAAGTGCTTTC-39). Amplified DNA was trans-
ferred to membranes and visualized using fluorescein end-labeled
probe specific for TCRAV2 (59-TAACATAAGAATGCACCGCT-
TACACC-39) and ALP-labeled anti-fluorescein antibody. Primers
for control TCRAC region were amplified using the primers 59-
CAGAACCCAGAACCTGCTGTG-39 and 59-ACGTGGCAT-
CACAGGGAA-39.N o m e n c l a t u r eo ft h eTCRA gene segments
was according to the ImMunoGeneTics (IMGT) database (http://
imgt.cines.fr).
Antigen Cross-Presentation
OVA-reactive CD8
+ T cells were isolated from spleens of DO
11.10 mice using MACS beads (Miltenyi Biotec). CD11c
+ DCs
(4610
5/well) were isolated using MACS beads (Miltenyi Biotec)
and incubated with 1 mg/ml OVA for 3 h, then co-cultured with
DO11.10 CD8
+ T (KJ1-26
+CD8
+) cells (2610
5/well) for 24 h,
and the expression of CD69 on DO11.10 CD8
+ T cells was
examined. IL-2 and IFNc in culture supernatants were measured
by ELISA (Biosource, Camarillo, CA).
To inhibit cross-presentation, mice were immunized in vivo with
250 mg of chloroquine (Sigma) 3 h prior to immunization with
500 mg OVA or PBS every 5 d. Presence of autoantibodies was
analyzed 2 d after each immunization, and proteinuria and
IFNc
+CD8
+ T cells were examined 9 d after the final
immunization.
Statistical Analysis
Statistical analyses were performed using Student’s t test, and
the data are expressed as the mean 6 SD.
Supporting Information
Figure S1 Induction of autoantibodies depends on correct
presentation of antigen to T cells. (A) BALB/c mice were
repeatedly injected i.p. with 25 mg of SEB or PBS every 5 d.
Sorted Vb8
+CD4
+splenocytes obtained 9 d after the final
immunization were stimulated in vitro with plate-bound 2 mg/ml
anti-CD3 (145-2C11; Cederlane, Ontario, Canada) and 5 mg/ml
anti-CD28 (37.51; BD PharMingen) antibodies for 24 h. Culture
supernatant assayed for IL-2 (mean 6 SD, 5 mice/group), or the
cells were labeled with carboxyfluorescein diacetate succinimidyl
ester (CFSE; Molecular Probes) and further cultured for 72 h
followed by flow cytometry. (B) Requirement of correct antigen
presentation for induction of RF. Induction of RF after
immunization 86 with SEB in B10.D2 and BALB/c mice
(efficient in presenting SEB) and in C57BL/6 (B6) mice (inefficient
in presenting SEB).
Found at: doi:10.1371/journal.pone.0008382.s001 (1.17 MB TIF)
Figure S2 Generation of autoantibodies after repeated immu-
nization with antigen. (A) The 8 week-old BALB/c mice were
injected i.p. with 500 mg OVA every 5 d, and serum RF and anti-
Sm, and anti-dsDNA antibodies (upper), and serum IgG and anti-
OVA antibodies (lower) were quantified by ELISA 2 d after
respective immunization. An arbitrary unit (AU) of 1.0 is the
equivalent titer in sera of MRL/lpr mice. Serum IgG was
quantified by ELISA (Bethyl Laboratories), and anti-OVA
antibody was quantified using mouse anti-OVA monoclonal
antibody (OVA-14; Sigma) as reference. (B) BALB/c mice were
immunized i.p. with 100 mg KLH every 5 d. Serum RF and anti-
Sm antibodies were measured by ELISA 2 d after respective
immunization, AU 1.0= equivalent detected in sera of MRL/lpr
mice.
Found at: doi:10.1371/journal.pone.0008382.s002 (1.00 MB TIF)
Figure S3 Induction of autoantibodies in CD8
+ T cell-deficient
mice. b2m-deficient mice were immunized with 500 mg OVA via
i.p. injection every 5 d, and IgG-RF, anti-dsDNA antibody, and
proteinuria were measured.
Found at: doi:10.1371/journal.pone.0008382.s003 (0.69 MB TIF)
Figure S4 Expression of V(D)J recombinase complex and
histopathology of OVA-immunized BALB/c mice. (A) Expression
of V(D)J recombinase complex after immunization 126with OVA
as detected using RT-PCR (upper left). GFP
+ cells in the CD4
+ T
cell of rag1/gfp knock-in mice after immunization 126with OVA
(lower left). Appearance and weights of spleens and a represen-
tative low-magnification view of the spleens from PBS- and OVA-
immunized mice (right, mean 6 SD, 9 mice/group). Enlarged
lymphoid follicles with marked germinal centers were seen in mice
immunized with OVA (H&E staining, bar =200 mm; original
magnification 620). (B) Representative renal and extra-renal
histopathology in the mice immunized 126 with OVA. A wire-
loop-like massive membranous glomerulonephritis in the kidney
(upper left) (PAS staining, bar =20 mm; original magnification
6400), plasma cell infiltrates around bile ducts (upper middle) (bar
=20mm; original magnification 6400), expansion of lymphoid
follicle in the white pulp of spleen (upper right) (bar =200 mm;
original magnification 640), focal infiltrates of mononuclear cells
to thyroid (lower left) (bar =50 mm; original magnification6100),
and diffuse infiltration of inflammatory cells into auricular
subcutaneous tissue (upper right) (bar =50 mm; original magni-
fication 6200).
Found at: doi:10.1371/journal.pone.0008382.s004 (6.01 MB TIF)
Figure S5 The de novo generation of IFNc-producing CD8
+ T
cells in recipient mice after cell transfer. Percentage of IFNc
+ cells
within the CD8
+ T population of the recipient mice was examined
2 weeks after cell transfer (mean 6 SD, 5 mice/group).
Found at: doi:10.1371/journal.pone.0008382.s005 (0.73 MB TIF)
Figure S6 Transfer of the ability to induce anti-ds DNA
antibody or tissue injury by transfer of CD4
+ or CD8
+ T cells,
respectively. Adoptive transfer of cells from OVA-immunized mice
into naı ¨ve BALB/c mice, with or without 16booster injection of
OVA (500 mg, 24 h post-transfer). Autoantibodies and proteinuria
measured 2 weeks later.
Found at: doi:10.1371/journal.pone.0008382.s006 (0.70 MB TIF)
Figure S7 Antigen-specific activation of T cells and the
expression of MHC class I on DC. (A) Spleen cells were cultured
with or without 1 mg/ml of OVA for 24 h, and the expression of
CD69 on CD4
+ T or CD8
+ T cells was examined by flow
cytometry. (B) DC from PBS- or OVA-immunized mice (PBS DC
or OVA DC) were incubated in the presence or absence of
chloroquine (CQ) (20 mg/ml) for 2 h and OVA (1 mg/ml) for 3h.
OVA- and/or CQ-pulsed DCs were stained with biotin-
conjugated anti-H-2k
d antibody (SF1-1.1; BD PharMingen) and
PE-conjugated streptavidin (BioLegend).
Found at: doi:10.1371/journal.pone.0008382.s007 (1.62 MB TIF)
Figure S8 Requirement of CD4
+ T cell help for inducing
autoimmune tissue injury. The mice were depleted of CD4
+ T
cells by treatment with 200 mg anti-CD4 antibody (Ab) (GK1.5;
BioLegend) 24 h prior to 66,9 6 and 126 immunization with
OVA. Control mice were injected with 200 mg rat IgG (CALTAG
Lab.). (A) A representative flow cytometry plot showing that CD4+
T cells were depleted to 5.5662.30% in the spleen and
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after 3rd treatment with anti-CD4 Ab. (B) Mice were immunized
126with OVA with or without adding anti-CD4 antibodies, and
the number of IFNc
+ cells within the CD8
+ T population (upper
and lower left) (mean 6 SD, 5 mice/group) and proteinuria (lower
right) were evaluated.
Found at: doi:10.1371/journal.pone.0008382.s008 (2.02 MB TIF)
Figure S9 Study on the requirement of autoantibody-inducing
CD4
+ T cells for autoimmune tissue injury. Neither OVA-specific
matured IFNc
+CD8
+ T cells or autoimmune tissue injury were
observed until BALB/c mice were immunized at least 106 with
OVA. The percent splenic IFNc
+CD8
+ T cells (left, mean 6 SD, 4
or 5 mice/group) and proteinuria (right) were examined after
immunization 66,8 6,1 0 6and 126with OVA.
Found at: doi:10.1371/journal.pone.0008382.s009 (0.67 MB TIF)
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